Urology Doctors in Clackamas, OR Accepting Medicare

11 Urology doctors found. Showing 1 - 11

Rou Wang, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Kaiser Permanente Sunnybrook Urology, Clackamas, OR 97015 Phone: 503-571-3488

Dr. Jeffrey Cottle Wheat, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880

Dr. Douglas Armstrong Ackerman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880

Paramjit Singh Chandhoke, M.D. Urology Medicare: Medicare Enrolled Practice Location: 10100 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-786-8435

Dr. Aaron Patrick Bayne, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2236

Matthew Forsyth, MD Urology Medicare: Medicare Enrolled Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-4177    Fax: 503-571-9032

Dr. Jeffrey Eaton Johnson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880

Dr. Stephen Farrell Lieberman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 10100 Se Sunnyside Rd, Mt Talbert Medical Office, Clackamas, OR 97015 Phone: 503-571-3787    Fax: 503-571-3772

Dr. Matti Abo Totonchy, M.D Urology Medicare: Not Enrolled in Medicare Practice Location: 10100 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-3786    Fax: 503-571-3772

Dr. Richard A Burt, MD Urology Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente Sunnybrook Medical Office, 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880

Richard William Steinberg, M.D. Urology - Pediatric Urology Medicare: Not Enrolled in Medicare Practice Location: 10100 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-786-8435

News Archive

Neuren and Metabolic collaborate to develop range of nerve repair compounds

Neuren Pharmaceuticals Ltd (Neuren) and Metabolic Pharmaceuticals Ltd (Metabolic) have announced that the two companies have agreed to collaborate to co-develop Neuren's class of Neuro-regenerative Peptides (NRPs) for the treatment of degenerative conditions such as peripheral neuropathy, motor neuron disease and repairing the brain or nerves after injuries such as spinal cord injury.

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the first quarter of 2013. Net loss in the first quarter of 2014 was $(9.3) million, or $(0.13) per share, which compares to net income of $0.3 million, or $0.00 per share, in the first quarter of 2013.

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice.

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

Read more Medical News

› Verified 4 days ago